Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Clascoterone may be an effective topical treatment for hair loss.

PPCM microspheres allow controlled finasteride release over 24 hours.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Finasteride boosts morphine's pain relief and prevents tolerance and withdrawal in rats.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Neuroactive steroids affect cocaine's rewarding effects through the sigma1 receptor.

Finasteride slows down motherly behavior in first-time pregnant rats.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Bimatoprost eye drops can cause temporary eyelid changes and may help with hair growth research.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

A combination of desogestrel and ethinyl oestradiol effectively reduces hair growth in hirsute women.

The new saw palmetto extract effectively inhibits an enzyme linked to prostate enlargement and may be as good as standard treatments.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

New Finasteride conjugate improves prostate treatment and vital signs in rats.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Finasteride reduces melanin production, possibly treating hyperpigmentation and melanoma, but needs more safety research.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.